Ambar Protein adopts FY26 financials and approves director re-appointments
- Ambar Protein Industries adopted FY26 financial statements at its 33rd AGM
- Bharat Dasrathbhai Patel and Shirishkumar Dashrathbhai Patel re-appointed by rotation
- Special resolutions approved variation in MD and WTD remuneration
- Meeting attended by 60 members with voting via e-voting and ballot papers

*this image is generated using AI for illustrative purposes only.
Ambar Protein Industries Limited adopted its financial statements for the year ended March 31, 2026, during its 33rd Annual General Meeting held on September 30, 2026. The meeting also approved the re-appointment of two directors retiring by rotation and variations in remuneration for key managerial personnel.
The meeting commenced at 10:00 am at the company's registered office in Ahmedabad, Gujarat. Gangaram Bhanjibhai Patel, Independent Director, served as chairman of the meeting. A total of 60 members attended the session, which concluded at 12:15 pm.
Key resolutions passed
Shareholders considered and adopted the audited Balance Sheet, Statement of Profit and Loss, and reports of the Board and Auditors for FY26. The following ordinary resolutions were placed for approval:
- Adoption of financial statements for the year ended March 31, 2026.
- Appointment of Bharat Dasrathbhai Patel (DIN: 07150579) who retires by rotation.
- Appointment of Shirishkumar Dashrathbhai Patel (DIN: 07150566) who retires by rotation.
- Approval of remuneration for cost auditors for FY27.
- Approval of related party transactions under Section 188 of the Companies Act, 2013.
Special resolutions on remuneration
The meeting also voted on special resolutions regarding executive compensation. These included variations in remuneration for Pradeep Chunilal Khetani (Managing Director) and Jayprakash J Vachhani (Whole Time Director). Additionally, shareholders approved the payment of commission to Bharatbhai D Patel, Non-Executive Non-Independent Director.
Voting and attendance details
Voting was conducted through remote e-voting from September 27 to September 29, 2026, and via ballot papers at the venue for members present who had not voted electronically. Bhumika Ranpura, Practising Company Secretary, served as the scrutinizer. The results of the voting, along with the scrutinizer's report, are scheduled for dissemination to stock exchanges and publication on the company website within two working days.
Historical Stock Returns for Ambar Protein Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -4.96% | -7.02% | -18.22% | +22.03% | -37.02% | 0.0% |
How will the approved variations in remuneration for the Managing Director and Whole Time Director impact Ambar Protein's operating margins in FY27?
What specific strategic initiatives are implied by the approval of related party transactions under Section 188 for the upcoming fiscal year?
Will the re-appointment of the retiring directors signal a continuation of the current management strategy or a shift in operational focus for the protein industry sector?


































